Furthermore, nanoformulationshave been proposed to efficiently control relevant pro-angiogenicpathways such as VEGF, Tie2/Angiopoietin-1, HIF-1α/HIF-2α,and TGF-β, providing powerful approaches to block tumor growthand metastasis. Here, EPAS1 is linked to neoplasm.